Target |
Mechanism FGF21R agonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism FGF21R agonists [+2] |
Active Org. |
Originator Org. |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism FGF21R agonists [+1] |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date10 Dec 2023 |
Sponsor / Collaborator |
Start Date17 Nov 2023 |
Sponsor / Collaborator |
Start Date19 Sep 2023 |
Sponsor / Collaborator |